Wedbush Issues Positive Outlook for BDTX Earnings
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) – Analysts at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for shares of Black Diamond Therapeutics in a research report issued on Tuesday, May 13th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of ($0.25) per share for the quarter, […]
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) – Analysts at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for shares of Black Diamond Therapeutics in a research report issued on Tuesday, May 13th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of ($0.25) per share for the quarter, […]
